Phase III trial of dasatinib in patients with recurrent glioblastoma multiforme

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00423735?term=RTOG-0627&rank=1

2. Intervention

   Dasatinib

3. Resource Description

   Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well dasatinib works in treating patients with recurrent glioblastoma multiforme or gliosarcoma.

4. Contact

   Berenberg, Jeffrey

5. PI

   Berenberg, Jeffrey

6. Topic

   glioblastoma multiforme

7. Study Population

   Men and women 18 years of age or older with biopsy-proven supratentorial glioblastoma multiforme within 4 weeks of registration, and meeting other disease and treatment-related criteria.

8. Funded by

   Radiation Therapy Oncology Group

9. Phase

   Phase 2 clinical trial

10. Performed by

    Clinical Protocol & Data Management Shared Resource